Remove tag digital-solutions
article thumbnail

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. Jolly Good is a medical technology company that develops VR solutions and AI-based medical and welfare services that analyse user behaviour in the VR space.

Hospitals 122
article thumbnail

Electronic smart packaging market to value nearly $3b in 2033

European Pharmaceutical Review

Yet apart from radio-frequency identification (RFID) tags and QR codes, adoption at scale has proved challenging overall, the report stated. Types of technologies such as wirelessly connected tags (active and passive) and sensors were also specified. This is driving the adoption of item-level smart labelling , the report noted.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PharmaShots Weekly Snapshots (March 13 - 17, 2023)

PharmaShots

5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted 5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted

article thumbnail

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. Analysing the world of digitally-native brands highlights three standout ways in which parts of their approach could be brought to the pharmaceutical world.

article thumbnail

Fidelis Specialty Pharmacy Selects Citus Health to Enable Real-Time Virtual Patient Communications and Faster Collection of Key Patient Data

Citus Health Specialty Pharmacy

Innovative specialty pharmacy provider for hemophiliac and bleeding disorder patients to implement Citus Health’s HIPAA-compliant digital health solution suite to improve patient and staff communications, therapy adherence rates and patient outcomes. Additional information is available on the Fidelis website at [link].

article thumbnail

Patient adherence – the key to restoring trust in pharma

pharmaphorum

Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of. The first issue that adherence and education solutions can address is the perceived lack of transparency from the pharmaceutical industry.

article thumbnail

Citus Health Announces Groundbreaking Home Healthcare Consumer Research

Citus Health Specialty Pharmacy

NEW YORK (PRWEB) June 10, 2021 Citus Health, a leading digital health solutions provider for the home-based care industry, announced the results of a brand new research study conducted in conjunction with Porter Research that captures the voice of the home healthcare consumer – the patient and family caregiver.